Pharma project management
Complybest Pharmaxpert LLP delivers end-to-end pharmaceutical solutions—analytical development, product development, clinical trials, and business expansion—ensuring global regulatory compliance, quality, and seamless CRO partnerships to accelerate growth and innovation.
01
Analytical Development
At Complybest Pharmaxpert LLP, we provide end-to-end analytical development services for formulations and APIs, supporting global regulatory markets including US FDA, EU, MHRA, LATAM, GCC, and beyond. With deep industry expertise, we help select the right CRO partners and deliver method development, validation, and transfer as per ICH guidelines. Our services span analytical method development, impurity profiling, raw material characterization, stability studies, forced degradation, dissolution profiling, and trace metal analysis. We also offer genotoxicity assessments, nitrosamine risk evaluation, and microbiological testing. Backed by advanced infrastructure—HPLC, GC, LC/MS, UV, IR, AAS, stability chambers—we ensure precise, compliant, and reliable results to accelerate your product development journey.
02
Business Development
The generic pharmaceutical industry continues to present immense opportunities in partnering, contract manufacturing, in-licensing, out-licensing, and product development. At Complybest Pharmaxpert LLP, we leverage our strong global network of small, medium, and large pharmaceutical companies to help clients identify new business areas and expand successfully across both regulated and emerging markets.
Our services for international business expansion include
Partner identification for distribution and contract manufacturing
Product development and marketing support
API and formulation sourcing
Worldwide representation in US, Canada, India, UK, and beyond.
Strategic partnerships for clinical trials and bioequivalence studies
Batch release and testing site support in the EU
03
Clinical Trial & Bioequivalence
At Complybest Pharmaxpert LLP, we provide complete solutions for Clinical Trials and Bioequivalence (BE) studies, ensuring compliance with global regulatory standards. Our services include CRO identification, auditing, and study monitoring, along with project management from proof-of-concept to global submissions. We support BA/BE studies, early and late-phase trials, biosimilars, inhalation, and other complex dosage forms. With advanced facilities—200+ beds, CAP/NABL accredited labs, US FDA approvals, and a volunteer database of 20,000+—we deliver reliable results. Our expert team manages bioanalytical method validation, PK/PD analysis, medical writing, regulatory submissions, and post-study services, helping clients accelerate development with quality and compliance.
04
Product development
At Complybest Pharmaxpert LLP, we believe successful pharma business begins with quality product development. With years of industry expertise, we help clients identify the right CRO partners and ensure seamless formulation and API development. Our global network and state-of-the-art facilities support markets including the US FDA, EU, MHRA, LATAM, GCC, SA, and India. Services include patent evaluation, QbD-based formulation, prototype development, reverse engineering, risk assessment, bioavailability enhancement, process validation, dossier development, and technology transfer. From lab scale to pivotal batches, we offer end-to-end support across diverse dosage forms—tablets, capsules, injectables, liquids, and semi-solids—backed by advanced equipment and regulatory compliance.
Fill out our quick form to request a complimentary consultation, and one of our Complybest Pharmaxpert LLP regulatory experts will reach out to schedule your personalized session. Gain insights, guidance, and expert advice to streamline your pharmaceutical compliance and regulatory processes.